Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R) Read more about Amgen Announces Update to U.S. Prescribing Information for Aranesp(R) and EPOGEN(R)
Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody Read more about Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody
The Colon Cancer Alliance Teams up with Joan Lunden for Amgen Sponsored Workshop Series Designed to Provide Support to Patients and Caregivers Read more about The Colon Cancer Alliance Teams up with Joan Lunden for Amgen Sponsored Workshop Series Designed to Provide Support to Patients and Caregivers
EU Commission Approves Updated Prescribing Information for Aranesp(R) Read more about EU Commission Approves Updated Prescribing Information for Aranesp(R)
KRAS Biomarker Analysis from Pivotal Vectibix(TM) Trial Published Read more about KRAS Biomarker Analysis from Pivotal Vectibix(TM) Trial Published
New Findings Show Enbrel(R) (etanercept) Significantly Reduced Levels of C-Reactive Protein, a Marker of Inflammation, in Patients with Moderate to Severe Plaque Psoriasis Read more about New Findings Show Enbrel(R) (etanercept) Significantly Reduced Levels of C-Reactive Protein, a Marker of Inflammation, in Patients with Moderate to Severe Plaque Psoriasis
Rob Lowe Launches Awareness Campaign About One Of The Most Dangerous And Unrecognized Side Effects Of Chemotherapy -- Infections Read more about Rob Lowe Launches Awareness Campaign About One Of The Most Dangerous And Unrecognized Side Effects Of Chemotherapy -- Infections
Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates Read more about Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates
FDA Approves Enbrel(R) as Treatment to Improve Physical Function in Rheumatoid Arthritis Patients Read more about FDA Approves Enbrel(R) as Treatment to Improve Physical Function in Rheumatoid Arthritis Patients
AMGEN FILES WITH FDA FOR USE OF KINERET(R) TO INHIBIT BONE AND JOINT DAMAGE DUE TO RHEUMATOID ARTHRITIS Read more about AMGEN FILES WITH FDA FOR USE OF KINERET(R) TO INHIBIT BONE AND JOINT DAMAGE DUE TO RHEUMATOID ARTHRITIS
